Abstract | CONTEXT: OBJECTIVE: To compare 2 commercial MUM1/IRF4 antibody formulations for accuracy in subtyping DLBCL against gene expression profiling, compare subtyping to patient survival, and evaluate the usefulness of GCB and non-GCB subtyping in relapsed and transformed DLBCL. DESIGN: Evaluation of 2 commercial MUM1/IRF4 antibodies, ICSTAT/M17 and Mum-1p, by using 40 cases of de novo, relapsed, and transformed DLBCL; and comparison of the results obtained with gene expression profiling and survival. RESULTS: Immunohistochemistry predicted the gene expression profiling subtype 71.8% and 69.2% of the time overall with use of the Mum-1p and ICSTAT/M17 antibodies, respectively, and 100% and 91.7% of the time when MUM1/IRF4 expression determined subtype. Gene expression profiling and immunohistochemistry revealed nearly identical 5-year overall survival rates for the GCB vs non-GCB subtypes (68.0% for GCB vs 24.7% for non-GCB with use of gene expression profiling [P = .03] and 70.2% vs 18.4%, respectively, with use of immunohistochemistry [P < .001]). When de novo, transformed, and relapsed cases were analyzed separately, 5-year overall survival rates were also significantly different. CONCLUSIONS: Immunohistochemistry can be used to subclassify DLBCL, including a very small series of transformed and relapsed cases, into GCB and non-GCB subtypes and predict survival rates similar to those predicted by use of gene expression profiling. The 2 MUM1/IRF4 antibodies performed similarly.
|
Authors | Chadwick F Haarer, Robin A Roberts, Yvette M Frutiger, Thomas M Grogan, Lisa M Rimsza |
Journal | Archives of pathology & laboratory medicine
(Arch Pathol Lab Med)
Vol. 130
Issue 12
Pg. 1819-24
(Dec 2006)
ISSN: 1543-2165 [Electronic] United States |
PMID | 17149956
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Biomarkers, Tumor
- Interferon Regulatory Factors
- interferon regulatory factor-4
|
Topics |
- B-Lymphocytes
(pathology)
- Biomarkers, Tumor
(analysis, classification)
- Cell Transformation, Neoplastic
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic
- Germinal Center
(pathology)
- Humans
- Immunophenotyping
- Interferon Regulatory Factors
(analysis)
- Lymphoma, B-Cell
(classification, genetics, mortality)
- Lymphoma, Large B-Cell, Diffuse
(classification, genetics, mortality)
- Neoplasm Recurrence, Local
(mortality, pathology)
- Reproducibility of Results
- Survival Rate
- Tissue Array Analysis
|